Welcome to our dedicated page for Lakeside Holding SEC filings (Ticker: LSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding a logistics company that straddles ocean freight, e-commerce fulfillment and temperature-controlled pharma isn’t easy. Lakeside Holding Limited’s multifaceted business means its disclosures span warehouse leases, cross-border customs risks and FDA transport rules—all scattered through dense forms. If you have ever searched for “Lakeside Holding Limited SEC filings explained simply” or wondered how the Hupan Pharmaceutical acquisition affects margins, you know the challenge.
Stock Titan turns that 300-page puzzle into a three-minute read. Our AI-powered summaries surface exactly where to find the Lakeside Holding Limited annual report 10-K simplified, the Lakeside Holding Limited quarterly earnings report 10-Q filing and every Lakeside Holding Limited 8-K material events explained. Need trading signals? Follow Lakeside Holding Limited insider trading Form 4 transactions with real-time alerts, or drill into Lakeside Holding Limited executive stock transactions Form 4 before freight-rate announcements. Each document arrives moments after EDGAR posts, paired with plain-English context so you are understanding Lakeside Holding Limited SEC documents with AI rather than skimming endless footnotes.
Whether you’re evaluating segment revenue shifts, tracking fuel-surcharge exposure, or comparing cold-chain compliance costs, our platform connects the right form to the right insight. Use the 10-Q for quarter-over-quarter freight volume trends, the proxy to explore Lakeside Holding Limited proxy statement executive compensation, and our dashboards for Lakeside Holding Limited earnings report filing analysis. With Lakeside Holding Limited Form 4 insider transactions real-time and interactive note tagging, professionals save hours while gaining a clearer picture of this cross-border supply-chain leader.
Lakeside Holding Limited reports results for the three months ended September 30, 2025, with total revenue of $6,099,889, up from $4,081,554 a year earlier, driven by growth in cross-border airfreight and new pharmaceutical distribution sales. Gross profit more than doubled to $1,108,767, but operating expenses rose to $2,380,391, leaving a loss from operations of $1,271,624.
Net loss was $1,357,216, similar to the prior period’s $1,335,407, and basic and diluted loss per share improved to $0.09 from $0.18 due to a larger share count. Cash used in operating activities increased to $4,016,518, while financing inflows of $3,672,316, including a $3,000,000 private placement and new loans, helped support liquidity.
Total assets rose to $18,635,189 and equity to $6,954,330 as of September 30, 2025, reflecting share issuances for consulting services, conversion of convertible notes, and the private placement. Loans payable increased to $2,419,103, and the company continues to rely on bank and third-party borrowings alongside equity financing to fund expansion and working capital.
Lakeside Holding Ltd (LSH) filed an initial insider ownership report on Form 3 for director Aik Siang Goh. The filing states that the reporting person currently has no securities beneficially owned in Lakeside Holding Ltd, and the tables for both non-derivative and derivative securities show no holdings. This establishes a formal record of the director’s ownership status as of the reported event date of 11/18/2025.
Lakeside Holding Ltd (LSH) director and Chief Operating Officer Yang Li filed an initial ownership report on Form 3. The filing states that no securities of Lakeside Holding Ltd are beneficially owned at this time. This means the executive currently reports no direct or indirect ownership of the company’s securities as of the event date of 11/18/2025.
Lakeside Holding Limited filed a Form 12b-25, notifying a late Quarterly Report on Form 10-Q for the period ended September 30, 2025. The company states it needs additional time to complete certain disclosures and that timely filing would have caused undue hardship and expense, in part due to circumstances referenced in Part IV.
The company expects to file the Form 10-Q on or before the fifth calendar day following the prescribed due date. The notification lists Long Yi as the contact and was signed by Long Yi, Chief Financial Officer (Principal Executive Officer).
Lakeside Holding Limited called a virtual special meeting on November 25, 2025 to seek stockholder approvals for major capital and governance changes. Proposals include increasing authorized common stock to 2,000,000,000 shares and authorizing 1,000,000,000 shares of blank check preferred. The Board also seeks to amend voting thresholds in the Articles to a simple majority and permit name changes without a stockholder vote, and to amend the Bylaws to reduce the quorum to one‑third of outstanding shares.
The agenda requests approval of a Treasury Reserve Strategy to hold Bitcoin and Ethereum, each capped so the Company’s total holdings do not exceed 5% of that cryptocurrency’s market capitalization at acquisition. It also asks approval under Nasdaq Rule 5635(d) for potential non‑public issuances of common stock and/or convertibles at not less than 80% of the Minimum Price, up to 100,000,000 shares and up to
Lakeside Holding Limited called a special meeting to seek approval for major corporate actions, including raising authorized common stock to 2,000,000,000 shares, creating a class of blank check preferred stock, and a potential company name change. The Board also proposes lowering certain voting thresholds and reducing the meeting quorum to one-third of shares entitled to vote.
The agenda includes a new Treasury Reserve Strategy adopting Bitcoin and Ethereum as primary treasury assets, with each capped at a 5% threshold of that cryptocurrency’s total market capitalization at time of acquisition. The Company also asks to pre‑approve non‑public issuances under Nasdaq Rule 5635(d) of up to 100,000,000 shares (and related convertibles) for up to $100,000,000 in aggregate gross proceeds, and a 2025 Equity Incentive Plan covering 5,000,000 shares. Shares outstanding were 17,427,559 as of October 16, 2025.
Lakeside Holding (LSH) filed its annual report, highlighting a shift to a two-segment model and a challenging year. Total revenue was $17.8 million, down 2.9% year over year, as cross-border freight solutions fell 17.9% amid U.S. trade policy changes and softer demand. The company added a new line in December 2024, generating $2.8 million from pharmaceutical distribution.
Gross profit was $2.9 million (16.2% margin) versus $3.7 million (20.3%) last year, reflecting margin compression in freight (8.8% vs. 20.3%). Pharma posted a 56.1% gross margin, aided by supplier discounts as a new customer. Operating costs rose sharply—selling expenses increased with launch marketing, and G&A climbed 79.1%—driving a net loss of $5.25 million versus a $0.23 million loss a year ago. Interest expense increased 271.5%.
Liquidity at year-end included $5.0 million in cash, a current ratio of 1.06:1, positive working capital of $0.6 million, and $2.8 million in stockholders’ equity. Shares outstanding were 17,427,559 as of October 10, 2025. Management cites tariff uncertainty and de minimis changes as headwinds while scaling the pharma segment.
FAQ
What is the current stock price of Lakeside Holding (LSH)?
What is the market cap of Lakeside Holding (LSH)?
